Tyra Biosciences (TYRA) Change in Accured Expenses (2020 - 2026)
Quarterly Change in Accured Expenses rose 427.4% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Mar 2026, down 14.97% year-over-year, with the annual reading at $3.4 million for FY2025, 552.82% up from the prior year.
Tyra Biosciences filings provide 7 years of Change in Accured Expenses readings, the most recent being $1.2 million for Q1 2026.
- Change in Accured Expenses hit $1.2 million in Q1 2026 for Tyra Biosciences, down from $2.2 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.1 million in Q4 2023 and bottomed at -$6.9 million in Q1 2024.
- Average Change in Accured Expenses over 5 years is $914470.6, with a median of $1.6 million recorded in 2022.
- The largest annual shift saw Change in Accured Expenses skyrocketed 9572.92% in 2023 before it crashed 241.54% in 2024.
- Tyra Biosciences' Change in Accured Expenses stood at $207000.0 in 2022, then skyrocketed by 2352.17% to $5.1 million in 2023, then plummeted by 56.5% to $2.2 million in 2024, then fell by 2.36% to $2.2 million in 2025, then tumbled by 44.57% to $1.2 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Change in Accured Expenses are $1.2 million (Q1 2026), $2.2 million (Q4 2025), and $2.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 107.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | -491,000.00 |
| Jun 30, 2025 | -491,000.00 |
| Mar 31, 2025 | -365,000.00 |
| Mar 31, 2025 | -365,000.00 |
| Dec 31, 2024 | 2.21 Mn |
| Dec 31, 2024 | 2.21 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | -6.91 Mn |
| Mar 31, 2024 | -6.91 Mn |
| Dec 31, 2023 | 5.08 Mn |
| Dec 31, 2023 | 5.08 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | -2.02 Mn |
| Mar 31, 2023 | -2.02 Mn |
| Dec 31, 2022 | 207,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Sep 30, 2022 | 48,000.00 |
| Jun 30, 2022 | 542,000.00 |
| Jun 30, 2022 | 542,000.00 |
| Mar 31, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 96,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 745,000.00 |
| Jun 30, 2021 | 745,000.00 |
| Mar 31, 2021 | -574,000.00 |
| Mar 31, 2021 | -574,000.00 |
| Dec 31, 2020 | 960,000.00 |
| Dec 31, 2020 | 960,000.00 |